National Early Inflammatory Arthritis Audit – Second Annual Report
The purpose of the NEIAA is to improve the quality of care for people living with inflammatory arthritis by measuring care provided to patients against the seven quality statements (QS) set out in NICE quality standard 33 (QS33). The audit also assesses how inflammatory arthritis affects people’s day-to-day function, mobility, sleep, wellbeing and ability to work, as well as reporting on clinical outcomes including hospitalisations, joint replacements and mortality.
This second annual report covers data gathered from 8 May 2019 to 7 May 2020. Data collection was non-mandatory from 27 March 2020 due to the COVID-19 pandemic and therefore data analysed predominantly reflects activity prior to the major impact of COVID-19.
This report incorporates long-term outcomes including mortality, joint replacements and unplanned admissions for the first time in the full annual report.
You can read the report by clicking on the link below.
Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
